http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2359681-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3efc348f58506bd74d7dc21cf5b9ce01 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-727 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-60 |
| filingDate | 2008-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2009-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21862e10e07c1672b3965f81c4b2eb6c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_479b5edd77aef58fe5365eaf5681aee4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80b1790de58750298d34992ac852f6f8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2898a418f58b038c026d7ef20e21a586 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6999ac6b9d6860231a7d349efd5f91d8 |
| publicationDate | 2009-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2359681-C1 |
| titleOfInvention | Antithrombotic composition on basis of heparin for peroral application |
| abstract | FIELD: medicine, pharmaceutics. n SUBSTANCE: invention concerns pharmacology and medicine and concerns an antithrombotic composition on a basis of heparin and its applications in quality of anticoagulant, antiplatelet, fibrinolitic, fibrindepolarising agent at peroral intake. The composition contains high-molecular heparin and in addition fish oil Eikonol in the form of its 25-45% solution in alimentary vegetable oil in quantity equal to 1 ml of Eikonol on 80-120 ME of antithrombic activity of high-molecular heparin. At use of liquid high-molecular heparin, parity Eikonol : heparin peer 1:0.018-0.022 (according to the volume) is used. At use of dry high-molecular heparina, a parity of 0.8-1.2 wt on 1 tot is used. For antithrombotic composition, refined alimentary oil, for example corn is used. n EFFECT: maintenance of peroral use of an agent on a basis heparin. n 6 cl, 3 ex, 1 tbl |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2456993-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2611662-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2454237-C1 |
| priorityDate | 2008-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 87.